onsdag 16. desember 2020

China Rolls Out Experimental COVID-19 Vaccine, But Doubts Remain

China is rolling out a homegrown COVID-19 vaccine, with more than a million people receiving the experimental jab earlier this year, but it remains beyond the reach of many, despite the ruling Chinese Communist Party (CCP)'s anti-poverty drive. A vaccine developed by China National Pharmaceutical Group (Sinopharm), has been given to government officials, students, and migrant workers heading overseas, The Guardian newspaper reported in November.

But the vaccines -- which retail at anything from 400 to 8,000 yuan -- aren't covered by medical insurance, and are priced beyond the reach of many people on middle-to-low incomes, RFA has learned. There are also safety concerns given the speed with which an experimental vaccine has been rolled out, and following a string of public health scandals triggered by fake, out-of-dat, and substandard vaccines that have sickened large numbers of people—many of them children—in recent years.

Beijing-based rights campaigner Guo Li said authorities at a residential complex in the southern Chinese city of Guangzhou had offered the jab to families living in the apartment block.